Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Clinical Nuclear Medicine
|
March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy
Philipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 29, 2023
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [<sup>18</sup>F]FDG
Yingjun Zhi, Rudolf A Werner, Andreas Schirbel, et al.
Frontiers in Immunology
|
April 3, 2026
[<sup>18</sup>F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis
Michael Gernert, Marc Schmalzing, Matthias Fröhlich, et al.
Cancers
|
January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Clinical Nuclear Medicine
|
September 27, 2023
Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas
Yingjun Zhi, Elena Gerhard-Hartmann, Philipp E Hartrampf, et al.
Molecular Imaging and Biology
|
August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma
Rudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Clinical Nuclear Medicine
|
March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy
Philipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 29, 2023
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [<sup>18</sup>F]FDG
Yingjun Zhi, Rudolf A Werner, Andreas Schirbel, et al.
Frontiers in Immunology
|
April 3, 2026
[<sup>18</sup>F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritis
Michael Gernert, Marc Schmalzing, Matthias Fröhlich, et al.
Cancers
|
January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Nuclear Medicine Communications
|
February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells
Alexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2024
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Clinical Nuclear Medicine
|
September 27, 2023
Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas
Yingjun Zhi, Elena Gerhard-Hartmann, Philipp E Hartrampf, et al.
Molecular Imaging and Biology
|
August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma
Rudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, et al.
Page
of 8